Gunilla Høyer‐Hansen

7.6k total citations
149 papers, 6.3k citations indexed

About

Gunilla Høyer‐Hansen is a scholar working on Cancer Research, Oncology and Hematology. According to data from OpenAlex, Gunilla Høyer‐Hansen has authored 149 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Cancer Research, 63 papers in Oncology and 42 papers in Hematology. Recurrent topics in Gunilla Høyer‐Hansen's work include Protease and Inhibitor Mechanisms (90 papers), Peptidase Inhibition and Analysis (50 papers) and Blood Coagulation and Thrombosis Mechanisms (41 papers). Gunilla Høyer‐Hansen is often cited by papers focused on Protease and Inhibitor Mechanisms (90 papers), Peptidase Inhibition and Analysis (50 papers) and Blood Coagulation and Thrombosis Mechanisms (41 papers). Gunilla Høyer‐Hansen collaborates with scholars based in Denmark, United States and United Kingdom. Gunilla Høyer‐Hansen's co-authors include Keld Danø, Ebbe Rønne, Michael Ploug, Niels Behrendt, Nils Brünner, Ib Jarle Christensen, Leif R. Lund, David J. W. Simpson, Hans Jørgen Nielsen and John Rømer and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Gunilla Høyer‐Hansen

148 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gunilla Høyer‐Hansen Denmark	48	3.5k	2.2k	2.1k	1.6k	1.2k	149	6.3k
Georgina S. Butler Canada	38	3.5k 1.0×	2.5k 1.1×	2.6k 1.2×	1.3k 0.8×	940 0.8×	58	6.7k
Michael Ploug Denmark	55	4.7k 1.3×	3.1k 1.4×	2.2k 1.0×	2.3k 1.4×	1.4k 1.2×	157	8.8k
Ulrich H. Weidle Germany	48	2.3k 0.7×	3.9k 1.8×	2.0k 0.9×	784 0.5×	924 0.8×	160	6.7k
Liliana Ossowski United States	41	4.8k 1.4×	3.7k 1.6×	2.9k 1.4×	1.9k 1.1×	1.6k 1.4×	79	8.5k
Viktor Magdolen Germany	46	2.6k 0.7×	3.0k 1.4×	2.0k 0.9×	1.3k 0.8×	890 0.8×	202	6.4k
Peter A. Andreasen Denmark	44	4.5k 1.3×	2.9k 1.3×	1.5k 0.7×	2.4k 1.5×	1.5k 1.3×	158	7.2k
Takeshi Itoh Japan	21	2.6k 0.7×	2.6k 1.1×	2.1k 1.0×	647 0.4×	757 0.6×	56	5.7k
Yves A. DeClerck United States	55	4.3k 1.2×	3.7k 1.6×	4.1k 1.9×	1.1k 0.7×	1.2k 1.0×	127	9.1k
George P. Tuszynski United States	44	1.4k 0.4×	3.1k 1.4×	804 0.4×	801 0.5×	868 0.7×	104	4.9k
Barry L. Marmer United States	16	4.6k 1.3×	1.7k 0.7×	2.7k 1.2×	1.8k 1.1×	1.2k 1.0×	17	6.1k

Countries citing papers authored by Gunilla Høyer‐Hansen

Since Specialization

Citations

This map shows the geographic impact of Gunilla Høyer‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunilla Høyer‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunilla Høyer‐Hansen more than expected).

Fields of papers citing papers by Gunilla Høyer‐Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunilla Høyer‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunilla Høyer‐Hansen. The network helps show where Gunilla Høyer‐Hansen may publish in the future.

Co-authorship network of co-authors of Gunilla Høyer‐Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Gunilla Høyer‐Hansen. A scholar is included among the top collaborators of Gunilla Høyer‐Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunilla Høyer‐Hansen. Gunilla Høyer‐Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abraham, Vivek C., Loan Miller, Zoltán Lászik, et al.. (2019). Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation. Clinical Transplantation. 33(3). e13487–e13487. 10 indexed citations

Almholt, Kasper, Josephine B. Hebsgaard, Anneline Nansen, et al.. (2017). Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models. The Journal of Immunology. 200(3). 957–965. 19 indexed citations

Ham, Boram, Ni Wang, María Celia Fernández, et al.. (2015). TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases. Cancer Research. 75(24). 5235–5247. 82 indexed citations

Christensen, Ib Jarle, Ben Vainer, Lars Bo Svendsen, et al.. (2015). The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study. Clinical Cancer Research. 22(10). 2427–2434. 16 indexed citations

Illemann, Martin, Gunilla Høyer‐Hansen, Ib Jarle Christensen, et al.. (2015). Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 33(4). 165.e15–165.e24. 25 indexed citations

Ahmad, Anwar, Prakash Saha, Colin E. Evans, et al.. (2014). The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers. Journal of Vascular Surgery Venous and Lymphatic Disorders. 3(2). 190–197. 6 indexed citations

Christensen, Ib Jarle, et al.. (2014). Circulating intact and cleaved forms of the urokinase-type plasminogen activator receptor: Biological variation, reference intervals and clinical useful cut-points. Clinica Chimica Acta. 439. 84–90. 11 indexed citations

Eynden, Gert G. Van den, Ali W. Majeed, Martin Illemann, et al.. (2013). The Multifaceted Role of the Microenvironment in Liver Metastasis: Biology and Clinical Implications. Cancer Research. 73(7). 2031–2043. 171 indexed citations

Christensen, Ib Jarle, Gunilla Høyer‐Hansen, Keld Danø, et al.. (2011). Urokinase receptor forms in serum from non-small cell lung cancer patients: Relation to prognosis. Lung Cancer. 74(3). 510–515. 30 indexed citations

10.

Brasso, Klaus, Peter Iversen, Helle Pappot, et al.. (2010). Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer. The Prostate. 71(8). 899–907. 47 indexed citations

11.

Bruyére, Françoise, Silvia Blacher, B. Detry, et al.. (2010). Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?. PLoS ONE. 5(3). e9653–e9653. 10 indexed citations

12.

Hénic, Emir, Christer Borgfeldt, Ib Jarle Christensen, Bertil Casslén, & Gunilla Høyer‐Hansen. (2008). Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian Cancer. Clinical Cancer Research. 14(18). 5785–5793. 64 indexed citations

13.

Larsen, Mette Bach, Ross W. Stephens, Nils Brünner, et al.. (2005). Quantification of Tissue Inhibitor of Metalloproteinases 2 in Plasma from Healthy Donors and Cancer Patients. Scandinavian Journal of Immunology. 61(5). 449–460. 20 indexed citations

14.

Hénic, Emir, Michael Sixt, Stefan R. Hansson, Gunilla Høyer‐Hansen, & Bertil Casslén. (2005). EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. Gynecologic Oncology. 101(1). 28–39. 25 indexed citations

15.

Illemann, Martin, Ulla Hansen, Hans Jørgen Nielsen, et al.. (2004). Leading-Edge Myofibroblasts in Human Colon Cancer Express Plasminogen Activator Inhibitor-1. American Journal of Clinical Pathology. 122(2). 256–265. 29 indexed citations

16.

Riisbro, Rikke, Ib Jarle Christensen, Timo Piironen, et al.. (2002). Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.. PubMed. 8(5). 1132–41. 100 indexed citations

17.

List, Karin, Gunilla Høyer‐Hansen, Ebbe Rønne, Keld Danø, & Niels Behrendt. (1999). Different mechanisms are involved in the antibody mediated inhibition of ligand binding to the urokinase receptor: a study based on biosensor technology. Journal of Immunological Methods. 222(1-2). 125–133. 35 indexed citations

18.

Høyer‐Hansen, Gunilla, Ebbe Rønne, Helene Solberg, et al.. (1992). Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.. Journal of Biological Chemistry. 267(25). 18224–18229. 213 indexed citations

19.

Dainese, Paola, Gunilla Høyer‐Hansen, & Roberto Bassi. (1990). THE RESOLUTION OF CHLOROPHYLL a/b BINDING PROTEINS BY A PREPARATIVE METHOD BASED ON FLAT BED ISOELECTRIC FOCUSING. Photochemistry and Photobiology. 51(6). 693–703. 85 indexed citations

20.

Høyer‐Hansen, Gunilla & Giorgio Casadoro. (1982). Unstable chloroplast ribosomes in the cold-sensitive barley mutanttigrina-o 34. Carlsberg Research Communications. 47(2). 103–118. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact